ATLANTA, GA – – (October 31, 2018) – – Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Nektar Therapeutics, Inc. (“Nektar” or the “Company”) (NASDAQ: NKTR) securities between November 11, 2017 through October 2, 2018. The class action seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. If you are a shareholder who purchased Nektar securities between November 11, 2017 and October 2, 2018 and suffered losses on that investment , you are encouraged to contact Corey D. Holzer Esq. at firstname.lastname@example.org or Marshall P. Dees, Esq. at email@example.com, or call the firm by toll-free telephone at (888) 508-6832. The case is pending in the United States District Court for the Northern District of California and the deadline to move for appointment as lead plaintiff is December 31, 2018.